1994 - 2001: Medical School, University of Cologne
04/2008: Habilitation in Experimental Internal Medicine, Faculty of Medicine, University of Cologne
06/2002: M.D., Medical School, University of Cologne, Magna cum Laude: “Detektion von Allelverlusten und molekulare Analyse von zellzyklus-regulierenden Genen und Tumorsuppressorgenen in Hodgkin Reed-Sternberg Zellen” (Supervisor: Jürgen Wolf, M.D., Department I for Internal Medicine, University of Cologne, Head: Volker Diehl, M.D.)
06/2001: Graduation from Medical School, University of Cologne, Summa cum Laude
2017: CMMC associate member (Center for Molecular Medicine Cologne)
2015: DKTK fellow (German Cancer Consortium), German Cancer Research Center (DKFZ)
07/12: Founder of Blackfield/ New Oncology AG, acquired by Siemens Healthcare in March 2016
2012 - present: W3 full professorship, Head of the Department of Translational Genomics, University of Cologne
2006 - 11/2012: Independent group leader in the Max Planck Institute for Neurological Research (associated member of the task force “Lung cancer” of the Center for Integrated Oncology and the Department I for Internal Medicine, University of Cologne)
2004 - 2006: Postdoctoral fellow, The Broad Institute of M.I.T. and Harvard & Dana-Farber Cancer Institute, Harvard Medical School, Cambridge Massachusetts (Group of Professor Matthew Meyerson, M.D., PhD)
2003 - 2004: Postdoctoral fellow, Department I for Internal Medicine and Center for Molecular Medicine (Group of Professor Dr. Jürgen Wolf)
2001 - 2002: Clinical residency (A.i.P.), Department I for Internal Medicine, University of Cologne, Medical Oncology/ Hematology
2017: Max-Delbrück-Preis der Universität zu Köln
2014: Walter und Christine Richtzenhain-Preis, Deutsches Krebsforschungszentrum
2014: Glaxo Smith Kline Scientific Award for Clinical Research 2014, GlaxoSmithKline Stiftung Deutschland
2013: Deutscher Krebspreis (German Cancer Award) 2013– Deutsche Krebsgesellschaft
2013: Coordinator of the system medicine Consortium “SMOOSE” in the e:Med program of the Federal Ministry for Education and Research (BMBF)
2012: Coordinator of a large-scale cancer sequencing consortium “Comprehensive molecular and histopathological characterization of small-cell lung cancer” funded by the German Cancer Aid (Deutsche Krebshilfe), which is part of the International Cancer Genome Consortium (ICGC)
2012: Coordinator of the joint research project PerMed funded by the German federal state NRW and the European Union (European Regional Development Fund: Investing in Your Future)
2008: Coordinator of the medical Genome Research Network “Oncogene dependencies” in the NGFNplus program of the Federal Ministry for Education and Research (BMBF)
2007: Young Investigator Award of IASLC
2006: Stipend of the International Association for the Study of Lung Cancer (IASLC)
2006: Fellow in Training Award of the American Association for Cancer Research
2005: Mildred-Scheel stipend of the German Cancer Aid
Professor (W3) and Director of the Department of Translational Genomics
University of Cologne
Department of Translational Genomics